![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/spacer.gif)
| Medicamento que se usa para tratar el cáncer de mama (seno) en estadio avanzado en las mujeres posmenopáusicas. Femara produce una disminución de la cantidad de estrógeno producido por el cuerpo. Es un tipo de inhibidor de la aromatasa. También se llama letrozol. |
![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081012084128im_/http://www.nci.nih.gov/images/spacer.gif) |